Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Disclaimer
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Zannad, F.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Zannad, F.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The European Society of Cardiology 2005. All rights reserved. For Permissions, please e-mail: journals.permissions{at}oupjournals.org

Acute heart failure syndromes: the ‘Cinderella’ of heart failure research

Faiez Zannad1,2,3,*

1INSERM, Centre d'investigation clinique CIC-INSERM CHU, Hôpital Jeanne d'Arc, 54200 Dommartin les Toul, Nancy, France
2CHU, Département des Maladies Cardio-Vasculaires, Nancy, France
3Université Henri Poincaré, Nancy, France

* Corresponding author. E-mail address: f.zannad{at}chu-nancy.fr

Acute heart failure syndromes (AHFS) comprises a heterogeneous set of conditions, which has received relatively little clinical attention, despite being one of the most commonly encountered syndromes in emergency medicine. The condition is one of the most common reasons for hospitalization in the developed world and is associated with substantial costs, in terms of morbidity, mortality, days spent in hospital, and financial expenditure. When compared with acute myocardial infarction, which accounts for a similar number of hospitalizations each year, the low number and small scale of clinical studies of AHFS is striking. This has resulted in a relative lack of progress in developing new therapies and in establishing optimal treatment strategies. New studies are exigently needed to address these needs. In the setting of this requirement for a greater understanding of AHFS, several population-based studies are in progress, with the aim of collecting epidemiological data on the condition. One such study is the EFICA observational cohort study of patients hospitalized with AHFS in France. This will provide information on the clinical and aetiological features, management, and outcomes of AHFS, which should steer the design of treatment strategies and clinical trials that are essential to improve management of this condition.

Key Words: Acute disease • Congestive heart failure, classification/epidemiology • Hospitalization/statistics and numerical data • Europe • Patient registry


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 EuropaceHome page
F. Zannad, N. Agrinier, and F. Alla
Heart failure burden and therapy
Europace, November 1, 2009; 11(suppl_5): v1 - v9.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Heart FailHome page
C. Adamopoulos, F. Zannad, R. Fay, A. Mebazaa, A. Cohen-Solal, L. Guize, Y. Juilliere, and F. Alla
Ejection fraction and blood pressure are important and interactive predictors of 4-week mortality in severe acute heart failure
Eur J Heart Fail, September 1, 2007; 9(9): 935 - 941.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.